PAHC Hedge Fund Ownership (Q1 2026)

Phibro Animal Health Corp (PAHC)

257 + Investors. Track Smart Money conviction in PAHC. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — PAHC

Based on 259 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 10 quarters in a row

last 6Q

For 10 consecutive quarters, more hedge funds added PAHC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

259 hedge funds hold PAHC right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +40% more funds vs a year ago

fund count last 6Q

+74 new funds entered over the past year (+40% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 57% buying

147 buying113 selling

Last quarter: 147 funds bought or added vs 113 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

📈

More new buyers each quarter (+27 vs last Q)

new funds entering per quarter

Funds opening a new PAHC position: 32 → 49 → 34 → 61. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

51% of holders stayed for 2+ years

■ 51% conviction (2yr+) ■ 22% medium ■ 27% new

132 out of 259 hedge funds have held PAHC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +43% but shares only +4% — price-driven

Value

+42%

+3%

Last quarter: the total dollar value of institutional holdings rose +43%, but actual share count only changed +4%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

30 → 32 → 49 → 34 → 61 new funds/Q

New funds entering each quarter: 32 → 49 → 34 → 61. A growing number of institutions are discovering PAHC each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 59% veterans vs 31% newcomers

■ 59% veterans ■ 9% 1-2yr ■ 31% new

Entry-cohort mix of 261 holders: 155 (59%) are 2+ year veterans, 24 entered 1–2 years ago, and 82 (31%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 58% AUM from top-100 funds

58% from top-100 AUM funds

49 of 257 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in PAHC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	257	225	14.22%
13F Shares	20M	19M	3.91%
Total Value	$1.03B	$724M	42.66%
New Positions	59	33	+26
Increased Positions	84	79	+5
Closed Positions	27	24	+3
Reduced Positions	85	82	+3
Total Calls	2	2	-
Total Puts	2	2	-
PUT/CALL Ratio	1.0	1.0	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

257

225

14.22%

13F Shares

20M

19M

3.91%

Total Value

$1.03B

$724M

42.66%

New Positions

+26

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

1.0

Neutral

Institutional Holders (2026 Q2)

257 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PAHC. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 PAHC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Globeflex Capital L P	0.76%	189,224	$5.9M
2	Ranger Investment Management, L.P.	0.58%	292,410	$9.2M
3	Rangeley Capital, LLC	0.57%	20,000	$628K
4	Virtus Advisers, LLC	0.52%	43,092	$1.4M
5	Cardinal Capital Management	0.38%	99,723	$3.1M
6	Dana Investment Advisors, Inc.	0.32%	387,867	$12.2M
7	Hussman Strategic Advisors, INC.	0.30%	42,000	$1.3M
8	Kings Path Partners LLC	0.26%	17,155	$694K
9	Hennessy Advisors Inc	0.22%	221,700	$7.0M
10	Wakefield Asset Management LLLP	0.22%	30,672	$963K
11	Oberweis Asset Management Inc/	0.20%	311,100	$9.8M
12	CastleKnight Management LP	0.20%	461,322	$14.5M
13	Integrated Quantitative Investments LLC	0.19%	37,396	$1.2M
14	Denali Advisors LLC	0.18%	57,277	$1.8M
15	Investors Portfolio Services LLC	0.18%	7,306	$229K
16	VARCOV Co.	0.17%	14,160	$445K
17	Cvfg LLC	0.15%	46,060	$1.4M
18	Curat Global, LLC	0.13%	4,184	$162K
19	Crawford Investment Counsel Inc	0.11%	205,256	$6.4M
20	NJ State Employees Deferred Compensation Plan	0.07%	16,000	$647K
21	Algert Global LLC	0.06%	151,208	$4.7M
22	Segall Bryant & Hamill, LLC	0.04%	95,068	$3.0M
23	Evolve Private Wealth, LLC	0.03%	17,920	$563K
24	Y-Intercept (Hong Kong) Ltd	0.03%	54,662	$1.7M
25	Balboa Wealth Partners	0.03%	7,898	$248K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Phibro Animal Health Corp (PAHC)

What does the Smart Money Trend signal show for PAHC?

Buying streak — 10 quarters in a row: For 10 consecutive quarters, more hedge funds added PAHC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PAHC?

Slight buying edge — 57% buying: Last quarter: 147 funds bought or added vs 113 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for PAHC holders?

Elite ownership — 58% AUM from top-100 funds: 49 of 257 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in PAHC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PAHC?

51% of holders stayed for 2+ years: 132 out of 259 hedge funds have held PAHC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Phibro Animal Health Corp (PAHC)

Smart Money Signals — PAHC

Buying streak — 10 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +40% more funds vs a year ago

Slight buying edge — 57% buying

More new buyers each quarter (+27 vs last Q)

51% of holders stayed for 2+ years

Value +43% but shares only +4% — price-driven

Growing discovery — still being found

Veteran-anchored — 59% veterans vs 31% newcomers

Elite ownership — 58% AUM from top-100 funds

Institutional Sentiment Summary — PAHC

Hedge Fund Ownership: PAHC

Market Analysis: PAHC

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: PAHC

Hedge Fund Positioning: PAHC

Statistics: PAHC

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Phibro Animal Health Corp (PAHC)

Welcome to 13Foresight!